Cargando…
Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report
INTRODUCTION: Irreversible electroporation (IRE) is a new minimally invasive tumor ablation technique which induces irreversible disruption of cell membrane integrity by changing the transmembrane potential resulting in cell death. Irreversible electroporation is currently undergoing clinical invest...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657545/ https://www.ncbi.nlm.nih.gov/pubmed/23668891 http://dx.doi.org/10.1186/1752-1947-7-128 |
_version_ | 1782270147972562944 |
---|---|
author | Niessen, Christoph Jung, Ernst-Michael Schreyer, Andreas G Wohlgemuth, Walter A Trabold, Benedikt Hahn, Joachim Rechenmacher, Michael Stroszczynski, Christian Wiggermann, Philipp |
author_facet | Niessen, Christoph Jung, Ernst-Michael Schreyer, Andreas G Wohlgemuth, Walter A Trabold, Benedikt Hahn, Joachim Rechenmacher, Michael Stroszczynski, Christian Wiggermann, Philipp |
author_sort | Niessen, Christoph |
collection | PubMed |
description | INTRODUCTION: Irreversible electroporation (IRE) is a new minimally invasive tumor ablation technique which induces irreversible disruption of cell membrane integrity by changing the transmembrane potential resulting in cell death. Irreversible electroporation is currently undergoing clinical investigation as local tumor therapy for malignant liver and lung lesions. This is the first case report to describe the successful palliative ablation of a presacral recurrence of an endometrial cancer to achieve locoregional tumor control and pain relief. CASE PRESENTATION: A 56-year-old Caucasian woman was referred for interventional treatment of an advanced local recurrence of endometrial cancer (11.9 × 11.6 × 14.9cm) with infiltration of the sacral bone and nerve plexus. Due to the immediate proximity to the sacral plexus, the patient could neither undergo surgical therapy nor a second radiation therapy. Due to its ablation mechanism irreversible electroporation was deemed to be the best therapy option. CONCLUSION: We showed in this case that a large tumor mass adjacent to a bundle of neural structures, the sacral plexus, can be widely ablated by irreversible electroporation with only minor temporary impairment of the neural function, even though a large infiltrating tissue volume (941cm(3)) was ablated. |
format | Online Article Text |
id | pubmed-3657545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36575452013-05-20 Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report Niessen, Christoph Jung, Ernst-Michael Schreyer, Andreas G Wohlgemuth, Walter A Trabold, Benedikt Hahn, Joachim Rechenmacher, Michael Stroszczynski, Christian Wiggermann, Philipp J Med Case Rep Case Report INTRODUCTION: Irreversible electroporation (IRE) is a new minimally invasive tumor ablation technique which induces irreversible disruption of cell membrane integrity by changing the transmembrane potential resulting in cell death. Irreversible electroporation is currently undergoing clinical investigation as local tumor therapy for malignant liver and lung lesions. This is the first case report to describe the successful palliative ablation of a presacral recurrence of an endometrial cancer to achieve locoregional tumor control and pain relief. CASE PRESENTATION: A 56-year-old Caucasian woman was referred for interventional treatment of an advanced local recurrence of endometrial cancer (11.9 × 11.6 × 14.9cm) with infiltration of the sacral bone and nerve plexus. Due to the immediate proximity to the sacral plexus, the patient could neither undergo surgical therapy nor a second radiation therapy. Due to its ablation mechanism irreversible electroporation was deemed to be the best therapy option. CONCLUSION: We showed in this case that a large tumor mass adjacent to a bundle of neural structures, the sacral plexus, can be widely ablated by irreversible electroporation with only minor temporary impairment of the neural function, even though a large infiltrating tissue volume (941cm(3)) was ablated. BioMed Central 2013-05-13 /pmc/articles/PMC3657545/ /pubmed/23668891 http://dx.doi.org/10.1186/1752-1947-7-128 Text en Copyright © 2013 Niessen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Niessen, Christoph Jung, Ernst-Michael Schreyer, Andreas G Wohlgemuth, Walter A Trabold, Benedikt Hahn, Joachim Rechenmacher, Michael Stroszczynski, Christian Wiggermann, Philipp Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report |
title | Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report |
title_full | Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report |
title_fullStr | Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report |
title_full_unstemmed | Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report |
title_short | Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report |
title_sort | palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657545/ https://www.ncbi.nlm.nih.gov/pubmed/23668891 http://dx.doi.org/10.1186/1752-1947-7-128 |
work_keys_str_mv | AT niessenchristoph palliativetreatmentofpresacralrecurrenceofendometrialcancerusingirreversibleelectroporationacasereport AT jungernstmichael palliativetreatmentofpresacralrecurrenceofendometrialcancerusingirreversibleelectroporationacasereport AT schreyerandreasg palliativetreatmentofpresacralrecurrenceofendometrialcancerusingirreversibleelectroporationacasereport AT wohlgemuthwaltera palliativetreatmentofpresacralrecurrenceofendometrialcancerusingirreversibleelectroporationacasereport AT traboldbenedikt palliativetreatmentofpresacralrecurrenceofendometrialcancerusingirreversibleelectroporationacasereport AT hahnjoachim palliativetreatmentofpresacralrecurrenceofendometrialcancerusingirreversibleelectroporationacasereport AT rechenmachermichael palliativetreatmentofpresacralrecurrenceofendometrialcancerusingirreversibleelectroporationacasereport AT stroszczynskichristian palliativetreatmentofpresacralrecurrenceofendometrialcancerusingirreversibleelectroporationacasereport AT wiggermannphilipp palliativetreatmentofpresacralrecurrenceofendometrialcancerusingirreversibleelectroporationacasereport |